Wan Jerry 4

What Happened
Jerry Wan, Principal Accounting Officer of Achieve Life Sciences (ACHV), was granted a derivative award covering 70,300 shares on 2026-01-28. The Form 4 reports the acquisition at $0.00 (no cash paid by the insider at grant). This is a compensation award (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-01-28; Form 4 filed: 2026-01-30 (timely filing).
• Security/transaction: Grant (derivative award/option) for 70,300 shares; reported price $0.00.
• Vesting: Award vests 25% on the first anniversary (Jan 28, 2026) then in substantially equal monthly installments over the following 36 months (per footnote).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• No indication of a 10b5-1 plan, tax withholding, cashless exercise, or late filing in the provided data.

Context
This filing reports a standard equity compensation grant to an executive. Such awards are common as part of pay/retention packages and do not represent an immediate open‑market purchase or sale. Because the award vests over time, economic ownership and any potential taxable event typically occur as portions vest or are exercised in the future.